五种晚期前列腺癌药物的相对搜索人气使用谷歌趋势
Sanjay Das1,2,3, Nadine A Friedrich4, James Daniels4
1Department of Urology, University of California - Los Angeles, Los Angeles, CA, USA. sanjay.das@cshs.org.
Prostate cancer and prostatic diseases
|September 7, 2023
概括
公众对晚期前列腺癌药物的兴趣各不相同,尽管有较新的选择,但双胺在低收入地区仍然很受欢迎. 这表明成本可能会影响患者寻找癌症治疗方法的搜索行为.
科学领域:
- 在瘤学瘤学.
- 医疗保健服务研究 医疗服务研究
- 数字健康数字健康
背景情况:
- 有许多FDA批准的药物用于晚期前列腺癌 (PC).
- 对这些PC药物的公众兴趣和搜索趋势尚不清楚.
- 这项研究考察了公众对五种常见的口服辅助激素疗法的兴趣,用于高级PC.
研究的目的:
- 为了比较公众对5种口服辅助激素治疗晚期前列腺癌的兴趣.
- 确定这些PC药物公共利益的州级预测因素.
- 使用谷歌趋势TM数据分析搜索趋势.
主要方法:
- 利用谷歌趋势TM查询美国的"恩扎胺"",阿比拉酸"",比卡胺"",阿帕胺"和"达罗胺"的搜索数据.
- 分析了2004年1月至2022年11月的数据,按月呈现相对搜索指数 (RSI).
- 检查了药物搜索受欢迎程度与国家一级社会经济因素之间的相关性.
主要成果:
- 在FDA批准后,观察到对abiraterone,enzalutamide和 apalutamide的搜索人气显著增加.
- 在COVID-19大流行期间 (2020年1月至7月),所有药物的搜索量显著下降.
- 在过去的五年中,恩扎胺和阿比拉是最被搜索的,紧随其后的是双胺. 在没有扩大医疗补助计划的州,家庭收入较低的州和没有保险的成年人比例较高的州,比卡胺的搜索量更高.
结论:
- 比卡胺保持了显著的公共利益,特别是在社会经济不利的州,可能是由于其成本较低.
- 公共搜索趋势反映了对晚期前列腺癌治疗方法的认识和兴趣.
- 这项研究为使用数字搜索数据对公众对PC疗法的参与提供了新的见解.
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:21Cancer Survival Analysis
381
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
381
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:07Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
01:15Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K